Patients Discontinuing Weight-Loss Injections Gain Back Weight at a Quadrupled Rate Than People Using Diet and Exercise

New research suggests that patients who come off blockbuster weight-loss injections like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who end conventional diet and exercise programs.

Research printed in a major health publication demonstrates that while overweight people often shed a large proportion of their body weight while on the medication, the weight returns at an average rate of 0.8 kg per month upon discontinuation.

"Individuals using these medications should be informed of the danger of rapid weight regain when the medication ends," warns expert Dr. Susan Jebb.

This pace of regain implies a return to original mass in about 18 months.

Analyzing Therapies

The research, which examined 37 of trials involving thousands of patients, contrasted the results of GLP-1 agonists with older methods.

The team note that people who shed pounds through lifestyle changes alone generally experience a slower creep back—perhaps 0.1 kg a month—after stopping.

The Reason for the Rapid Regain

Nutrition scientists believe the mode of action of the injections accounts for the heightened rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which controls hunger.

"Sustained high doses of GLP-1 levels far above than normal might result in the system to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this medication results in hunger is no longer kept in check, making binge eating much more probable."

A Chronic Condition?

The NHS recommend the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.

Professionals argue that, due to the likelihood of weight regain, the therapy is often long-term.

This view is reinforced by drug manufacturers, who state that the findings "underscore the chronic character of excess weight," similar to managing conditions like diabetes.

Patient Testimonies

People who have stopped the medication report a intense return of appetite.

"It was like a switch flipping and you become starving," described a patient.

This difficulty is compounded if patients have not adopted lasting dietary or behavioural changes during treatment.

Widespread Use

Survey data suggest that a significant number of people in the UK have used these injections in the past year, with interest continuing to grow.

• Use is more common among females compared to males.
• The middle-aged demographic shows the highest level of interest.
• Many obtain the drugs through private prescriptions rather than public health services.

Finally, clinicians caution that while these medications are effective tools for weight loss, they are not a standalone cure and lasting health benefits hinges on ongoing lifestyle changes.